Extracorporeal Membrane Oxygenation in Pediatric Trisomy 21: 30 Years of Experience from the Extracorporeal Life Support Organization Registry.

Abstract

OBJECTIVES To describe the use of extracorporeal membrane oxygenation (ECMO) in patients with trisomy 21 (T21), to identify risk factors for hospital mortality, and to compare outcomes with those of patients without T21. STUDY DESIGN Children under age 18 years registered in the Extracorporeal Life Support Organization Registry were included. Comparisons… (More)
DOI: 10.1016/j.jpeds.2015.04.048

Topics

Cite this paper

@article{Cashen2015ExtracorporealMO, title={Extracorporeal Membrane Oxygenation in Pediatric Trisomy 21: 30 Years of Experience from the Extracorporeal Life Support Organization Registry.}, author={Katherine Cashen and Ravi R. Thiagarajan and James J. Collins and Peter T. Rycus and Carl Lewis Backer and Marleta Reynolds and John Costello}, journal={The Journal of pediatrics}, year={2015}, volume={167 2}, pages={403-8} }